Iongen Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $15.1M

  • Investors
  • 5

Iongen Therapeutics General Information

Description

Developer of innovative pain treatment drugs designed to target sodium ion channels. The company offers Nav1.8 inhibitors, Nav1.7/1.8 dual inhibitors, ION channel modulators, small-molecule analgesics, and non-opioid therapeutic solutions, enabling chronic pain patients to access effective analgesia without addiction risks through a proprietary drug discovery platform.

Contact Information

Website
www.iongentherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 19th Floor, Building A, Zhongdan Garden
  • Number 3-1, Xinjinhu Road, Jiangbei New District
  • Nanjing, Jiangsu 210031
  • China
+86 025
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 19th Floor, Building A, Zhongdan Garden
  • Number 3-1, Xinjinhu Road, Jiangbei New District
  • Nanjing, Jiangsu 210031
  • China
+86 025

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Iongen Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 14-Jan-2025 $15.1M Completed Generating Revenue
1. Seed Round 01-Sep-2021 Completed Startup
To view Iongen Therapeutics’s complete valuation and funding history, request access »

Iongen Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Insight Capital (Taicang) Venture Capital Minority
Qiming Venture Partners Venture Capital Minority
THG Ventures Venture Capital Minority
China Growth Capital Venture Capital Minority
Jiangbei Investment Group Growth/Expansion Minority
To view Iongen Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Iongen Therapeutics FAQs

  • When was Iongen Therapeutics founded?

    Iongen Therapeutics was founded in 2021.

  • Where is Iongen Therapeutics headquartered?

    Iongen Therapeutics is headquartered in Nanjing, China.

  • What industry is Iongen Therapeutics in?

    Iongen Therapeutics’s primary industry is Drug Discovery.

  • Is Iongen Therapeutics a private or public company?

    Iongen Therapeutics is a Private company.

  • What is Iongen Therapeutics’s current revenue?

    The current revenue for Iongen Therapeutics is .

  • How much funding has Iongen Therapeutics raised over time?

    Iongen Therapeutics has raised $16.6M.

  • Who are Iongen Therapeutics’s investors?

    Insight Capital (Taicang), Qiming Venture Partners, THG Ventures, China Growth Capital, and Jiangbei Investment Group have invested in Iongen Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process